Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Shortage Legislation: Sen. Blumenthal Calls For More Extensive Effort

This article was originally published in The Pink Sheet Daily

Executive Summary

Democratic Senator has terse exchange with FDA at hearing and says Congress must do more than what is already in pending legislation. Blumenthal said he is willing to consider the Generic Pharmaceutical Association proposal calling for an independent third party to compile supplier data and predict coming shortages.

You may also be interested in...



House FDA Appropriations Chairman Has Budget-Cutting History

Alabama Republican Robert Aderholt takes over as House FDA appropriations subcommittee chair, while Maryland Democrat Barbara Mikulski now runs the Senate Appropriations Committee.

House FDA Appropriations Chairman Has Budget-Cutting History

Alabama Republican Robert Aderholt takes over as House FDA appropriations subcommittee chair, while Maryland Democrat Barbara Mikulski now runs the Senate Appropriations Committee.

New House FDA Appropriations Chair Aderholt An Unknown

Alabama Republican Robert Aderholt takes over as FDA appropriations subcommittee chair after running homeland security subcommittee; Mikulski to run Senate Appropriations Committee.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS073948

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel